Sanara MedTech
SMTI
44 hedge funds and large institutions have $24.5M invested in Sanara MedTech in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
19% more capital invested
Capital invested by funds: $20.6M → $24.5M (+$3.89M)
10% more funds holding
Funds holding: 40 → 44 (+4)
0.8% more ownership
Funds ownership: 8.46% → 9.26% (+0.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$856K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$639K |
| 3 |
Squarepoint
New York
|
+$422K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$342K |
| 5 |
BlackRock
New York
|
+$307K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$728K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$371K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$272K |
| 4 |
WIA
World Investment Advisors
Santa Barbara,
California
|
-$150K |
| 5 |
Bank of New York Mellon
New York
|
-$86.7K |
SMTI Hedge Fund Activity: Q3 2024 in Review
44 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2024, worth a combined $24.5M — up 19% from $20.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SMTI positions and 3 closed out — a net gain of 4 holders — while 16 added to existing stakes and 10 trimmed.
The largest buyer was Vanguard Group, adding an estimated $856K. The largest seller was Janney Montgomery Scott, cutting an estimated $728K.
- 44 institutional investors held Sanara MedTech (SMTI) as of Q3 2024, up from 40 in Q2 2024.
- Funds reported $24.5M of Sanara MedTech stock for Q3 2024, up 19% quarter-over-quarter.
- 7 funds opened new Sanara MedTech positions in Q3 2024 and 3 closed out, a net change of +4 holders.
- The largest Sanara MedTech buyer in Q3 2024 was Vanguard Group, an estimated $856K added.
- The largest Sanara MedTech seller in Q3 2024 was Janney Montgomery Scott, an estimated $728K sold.
Based on aggregated 13F filings for Q3 2024.